Streetbeat News

Revenues

FCG

USO

Oil prices fell as OPEC+ postponed its meeting to discuss output quotas due to a dispute over African quota with Nigeria and Angola. Brent crude dropped below $80 a barrel, and WTI fell to $74.61. The USO ETF declined by 1.7% in pre-market trade, while the FCG ETF was down 2.6%. High supply and lower demand, along with record U.S. production and warmer weather, are influencing the market. Saudi Arabia and Russia may consider deeper production cuts at the upcoming meeting, which could impact prices.

Portfolio Pulse from Neil Dennis

November 27, 2023 | 1:34 pm

SHOP

Shopify Inc (NYSE:SHOP) stock is rising after announcing a Black Friday sales record of $4.1 billion by its merchants, a 22% increase from 2022. Sales peaked at $4.2 million per minute, with clothing, personal care, and jewelry as top categories. The average cart price was $110.71, with the U.S., U.K., and Canada as top selling countries. The stock was up 3.85% at $73.05.

Portfolio Pulse from Adam Eckert

November 27, 2023 | 1:33 pm

ADBE

SPY

Adobe predicts consumer spending to reach $12B-$12.4B on Cyber Monday, indicating a significant day for retail and e-commerce sectors.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:30 pm

BIMI

BIMI International Medical Inc. reported H1 2023 revenues of $8,755,303, a significant increase from $5,543,745 in H1 2022. The rise is attributed to the acquisition of Phenix Bio Inc. on March 15, 2023. Gross margins improved to 52% in H1 2023 from 15% in H1 2022, reflecting the high-margin herbal supplements sold by Phenix Bio. BIMI also saw a positive shift in its cash position and working capital, with cash at $1,931,744 and working capital at $6,604,643 as of June 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:27 pm

SYTA

Siyata Mobile Inc. has received a purchase order for its SD7 rugged handsets and VK7 vehicle kits, which will be used in a new vertical market. This development could indicate an expansion of Siyata's market reach and potential growth in sales.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:14 pm

CATX

Perspective Therapeutics has announced the publication of four preclinical studies that support the company's discovery pipeline. These studies are crucial for the advancement of the company's research and development efforts in creating innovative treatments. The announcement is likely to be viewed positively by investors as it demonstrates progress in the company's pipeline.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:13 pm

IHRT

iHeartMedia, Inc. expects to receive approximately $100M from the sale of Broadcast Music, Inc. to a group led by New Mountain Capital, LLC. The proceeds from iHeartMedia's equity interest in BMI will be used for general corporate purposes, potentially including debt repayment. The sale is subject to BMI shareholder and regulatory approvals and is expected to close by the end of Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:11 pm

TAK

Takeda (NYSE:TAK) will present 17 company-sponsored and nine collaborative abstracts at the 65th American Society of Hematology Annual Meeting. The presentations will include data supporting the recent FDA approval of ADZYNMA for cTTP treatment, Phase 1 data for TAK-755 in sickle cell disease, and a meta-analysis for hemophilia A. Oncology presentations will cover ICLUSIG in Ph+ ALL and ADCETRIS in Hodgkin lymphoma. The research aims to improve treatment for hematologic diseases with high unmet patient need.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:11 pm

ACON

PHG

SIEGY

Aclarion, Inc. has reached a significant commercial milestone by completing 1,000 Nociscan exams, all of which have been conducted on Siemens MRI scanners. The company anticipates further acceleration of exam volumes as Philips MRI scanners are integrated into their service offerings.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:10 pm

SPY

USA Building Permits for the month showed an increase of 1.8%, surpassing the estimated 1.1%. This is a significant improvement from the previous month's decline of 4.5%.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 1:01 pm